High Tide’s NuLeaf Naturals Targets Role in New U.S. Medicare CBD Pilot
End of Quarter Sale - 50% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
High Tide ( (TSE:HITI) ) just unveiled an update.
High Tide’s U.S. hemp-derived CBD subsidiary NuLeaf Naturals is moving to participate in a new U.S. Centers for Medicare & Medicaid Services Innovation Center pilot that allows certain Medicare-focused organizations to provide eligible hemp-derived CBD products to beneficiaries at no cost. With cGMP-certified, FDA-registered facilities and a portfolio of THC-free and broad-spectrum CBD products tailored to program rules, NuLeaf aims to supply Accountable Care Organizations and oncology practices taking part in the Beneficiary Engagement Incentive initiative.
Management says NuLeaf’s readiness and existing role in the National Compassionate Care Council give it an advantageous position as CMS seeks real-world data on CBD therapies in physician-guided care. If the pilot scales and potentially expands to additional CMS models over time, High Tide expects it could become a meaningful growth driver for its U.S. CBD business while advancing the integration of hemp-derived cannabinoid products into federally supported healthcare frameworks.
The most recent analyst rating on (TSE:HITI) stock is a Hold with a C$3.00 price target. To see the full list of analyst forecasts on High Tide stock, see the TSE:HITI Stock Forecast page.
Spark’s Take on HITI Stock
According to Spark, TipRanks’ AI Analyst, HITI is a Neutral.
The score is primarily held back by weak profitability and elevated leverage despite improving operating/free cash flow, alongside bearish technical signals (below major moving averages with negative MACD). A high P/E further weighs on the outlook given ongoing net losses.
To see Spark’s full report on HITI stock, click here.
More about High Tide
High Tide Inc. is a Calgary-based, retail-focused cannabis enterprise with diversified, vertically integrated operations across the cannabis value chain. Through subsidiaries such as NuLeaf Naturals and its global Canna Cabana retail brand, the company targets both recreational cannabis consumers and the U.S. hemp-derived CBD market, emphasizing quality-controlled, compliant products for healthcare and wellness applications.
Average Trading Volume: 76,927
Technical Sentiment Signal: Sell
Current Market Cap: C$278.6M
For a thorough assessment of HITI stock, go to TipRanks’ Stock Analysis page.
